Aleksandra Banaszkiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aleksandra Banaszkiewicz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Izabella Łazowska-Przeorek
Department of Pediatric Gastroenterology and Nutrition Medical University of Warsaw Warsaw Poland
2 shared publications - Jarosław Walkowiak
Department of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, Szpitalna 27/33, 60-572 Poznań, Poland
2 shared publications - Katarzyna Karolewska-Bochenek
Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Warsaw, Poland
2 shared publications - Marcin Dziekiewicz
Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Warsaw, Poland
2 shared publications - Agnieszka Gawrońska
Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Warsaw, Poland
1 shared publication - Aleksandra Lisowska
Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland
1 shared publication
Latest Publications
- 1 November 2017
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 65 (5) , e110
“Cobblestone” Appearance of Esophagus
- 1 November 2017
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 65 (5) , e110
“Cobblestone” Appearance of Esophagus
- 15 May 2017
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 11 (11) , 1402
Budesonide MMX in Paediatric Patients With Ulcerative Colitis
- 15 May 2017
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 11 (11) , 1402
Budesonide MMX in Paediatric Patients With Ulcerative Colitis
- 1 March 2016
- Published by Elsevier in Advances in Medical Sciences
- Vol. 61 (1) , 28-31
Overweight and obesity in children with newly diagnosed inflammatory bowel disease
- 1 March 2016
- Published by Elsevier in Advances in Medical Sciences
- Vol. 61 (1) , 28-31
Overweight and obesity in children with newly diagnosed inflammatory bowel disease
- 1 October 2015
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 61 (4) , 523-524
PP‐9 NORMAL VALUES OF 3D HIGH‐RESOLUTION ANORECTAL MANOMETRY IN CHIDREN
- 1 October 2015
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 61 (4) , 523-524
PP‐9 NORMAL VALUES OF 3D HIGH‐RESOLUTION ANORECTAL MANOMETRY IN CHIDREN
- 19 September 2015
- Vol. 19 (2) , 167-73
Fecal pyruvate kinase is not suitable for discrimination between inflammatory bowel disease exacerbation and acute gastroenteritis.
In inflammatory bowel diseases (IBD) diarrhea can be caused by exacerbation and/or infectious agents. Fecal calprotectin (FC) is a well-established biomarker of intestinal inflammation in IBD. However, its usefulness in depiction of IBD exacerbation from infectious diarrhea is limited. The value of fecal pyruvate kinase isoenzyme type 2 (M2-PK) in this application remains unknown. To compare the performance of M2-PK and FC in discriminating between diarrhea caused by IBD and infectious agents. One hundred three patients were enrolled for the study, including 32 with ulcerative colitis (UC), 21 with Crohn's disease (CD), 29 with acute diarrhea caused by rotavirus (AD-RV), and 21 with acute diarrhea caused by Salmonella enteritidis (AD-SE). M2-PK and FC were measured using ELISA. Areas under receiver operating characteristic curves (AUCs), sensitivities and specificities for both tests in distinguishing between patient subgroups with moderate to severe UC and CD from AD-RV and AD-SE were calculated. Differences in AUCs between M2-PK and FC for distinguishing UC [CD] from AD-RV were -0.06 (p < 0.028) [-0.10 (p < 0.0018)] and for differentiating UC [CD] from AD-SE were 0.03 (NS) [-0.19(p < 0.0011)].M2-PK sensitivities and specificities in distinguishing UC [CD] from AD-RV were 75.0%[71.4%] and 89.7% [89.7%] and for differentiation of UC [CD] from AD-SE were 56.3% [71.4%] and 95.2[57.1%]. The performance of M2-PK in distinguishing between children with moderate-to-severe IBD and patients with infectious gastroenteritis was inferior to FC. Neither test had sensitivity ands pecificity sufficient for everyday clinical application.
- 19 September 2015
- Vol. 19 (2) , 167-73
Fecal pyruvate kinase is not suitable for discrimination between inflammatory bowel disease exacerbation and acute gastroenteritis.
In inflammatory bowel diseases (IBD) diarrhea can be caused by exacerbation and/or infectious agents. Fecal calprotectin (FC) is a well-established biomarker of intestinal inflammation in IBD. However, its usefulness in depiction of IBD exacerbation from infectious diarrhea is limited. The value of fecal pyruvate kinase isoenzyme type 2 (M2-PK) in this application remains unknown. To compare the performance of M2-PK and FC in discriminating between diarrhea caused by IBD and infectious agents. One hundred three patients were enrolled for the study, including 32 with ulcerative colitis (UC), 21 with Crohn's disease (CD), 29 with acute diarrhea caused by rotavirus (AD-RV), and 21 with acute diarrhea caused by Salmonella enteritidis (AD-SE). M2-PK and FC were measured using ELISA. Areas under receiver operating characteristic curves (AUCs), sensitivities and specificities for both tests in distinguishing between patient subgroups with moderate to severe UC and CD from AD-RV and AD-SE were calculated. Differences in AUCs between M2-PK and FC for distinguishing UC [CD] from AD-RV were -0.06 (p < 0.028) [-0.10 (p < 0.0018)] and for differentiating UC [CD] from AD-SE were 0.03 (NS) [-0.19(p < 0.0011)].M2-PK sensitivities and specificities in distinguishing UC [CD] from AD-RV were 75.0%[71.4%] and 89.7% [89.7%] and for differentiation of UC [CD] from AD-SE were 56.3% [71.4%] and 95.2[57.1%]. The performance of M2-PK in distinguishing between children with moderate-to-severe IBD and patients with infectious gastroenteritis was inferior to FC. Neither test had sensitivity ands pecificity sufficient for everyday clinical application.